health partners glp 1 coverage Medicaid of and Spending on GLP-1s Quantum Health Partners with Vida

Facial volume loss, often referred to as Ozempic face, and muscle loss are typically linked to rapid weight loss rather than the medication itself

"As we thoroughly collate and evaluate three years of studying GLP-1 obesity drug trends among real-world populations, new patterns are emerging that help us understand how these drugs are being used and how external factors may be impacting persistence and health outcomes," said Pat Gleason, PharmD, assistant vice president, health outcomes, at Prime

The information here is educational and not a substitute for clinical judgment

The aim is steady, sustainable progress rather than dramatic short-term weight loss